2015
HIV+ patient on suppressive antiretroviral therapy with steroid injection-induced myopathy
Farber SJ, Sutton RE. HIV+ patient on suppressive antiretroviral therapy with steroid injection-induced myopathy. AIDS 2015, 29: 1422-1424. PMID: 26098599, DOI: 10.1097/qad.0000000000000738.Peer-Reviewed Original Research
2013
A Study of Financial Incentives to Reduce Plasma HIV RNA Among Patients in Care
Farber S, Tate J, Frank C, Ardito D, Kozal M, Justice AC, Scott Braithwaite R. A Study of Financial Incentives to Reduce Plasma HIV RNA Among Patients in Care. AIDS And Behavior 2013, 17: 2293-2300. PMID: 23404097, PMCID: PMC3742414, DOI: 10.1007/s10461-013-0416-1.Peer-Reviewed Original ResearchConceptsViral load suppressionFeasibility outcomesPatient acceptabilityPatient comprehensionPlasma HIV RNADetectable viral loadViral load testsSingle-site studyEligible patientsHIV careHIV RNAART adherenceViral loadHIV transmissionOwn controlPatientsPatient workflowFinancial incentivesOutcomesCareDownstream costsIncentive sizeBiological outcomesAcceptabilityClinic
2009
Development of an Electronic Medical Record-Based Clinical Decision Support Tool to Improve HIV Symptom Management
Nader CM, Tsevat J, Justice AC, Mrus JM, Levin F, Kozal MJ, Mattocks K, Farber S, Rogers M, Erdos J, Brandt C, Kudel I, Braithwaite R. Development of an Electronic Medical Record-Based Clinical Decision Support Tool to Improve HIV Symptom Management. AIDS Patient Care And STDs 2009, 23: 521-529. PMID: 19538046, PMCID: PMC3048777, DOI: 10.1089/apc.2008.0209.Peer-Reviewed Original ResearchMeSH KeywordsAdultDecision Making, Computer-AssistedDecision Support Systems, ClinicalFemaleHIV InfectionsHumansMaleMedical Records Systems, ComputerizedMiddle AgedPatient SatisfactionPilot ProjectsPractice Guidelines as TopicPractice Patterns, Physicians'Severity of Illness IndexSurveys and QuestionnairesUnited StatesUnited States Department of Veterans AffairsConceptsClinical decision support toolVeterans Health Administration electronic medical recordsElectronic medical recordsSymptom managementMedical recordsProvider awarenessProgress notesClinical HIV careHIV symptom managementEMR notesHIV careHIV clinicClinical responseControl patientsHIV diseaseCommon symptomsPoint of careHIV symptomsProvider notesPatients' perceptionsIntervention groupIntervention periodCare plansPatientsSymptomsRaltegravir With Unboosted Atazanavir 300 mg Twice Daily in Antiretroviral Treatment-Experienced Participants
Gupta S, Lataillade M, Farber S, Kozal MJ. Raltegravir With Unboosted Atazanavir 300 mg Twice Daily in Antiretroviral Treatment-Experienced Participants. Journal Of The International Association Of Providers Of AIDS Care (JIAPAC) 2009, 8: 87-92. PMID: 19270153, DOI: 10.1177/1545109709332471.Peer-Reviewed Original ResearchConceptsMean CD4 count increaseCD4 count increaseCombination of raltegravirTreatment-experienced patientsPotent antiretroviral activityCopies/mLProtease inhibitorsARV agentsUnboosted atazanavirHIV RNAImmunologic outcomesTwice DailyAntiretroviral treatmentARV therapyAntiretroviral agentsCase seriesHIV integrase inhibitorsTherapeutic failureAntiretroviral activityRaltegravirAtazanavirIntegrase inhibitorsAdverse effectsCells/Count increase